MYF5 and cancer: Rhabdomyosarcomas (RMS) are high-grade malignant tumors exhibiting partial myogenic differentiation due to aberrant expression of muscle regulatory factors (MRFs) such as myogenic factor 5 (MYF5), myoblast determination protein 1 (MYOD), and myogenin (MYOG)[1].